TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский
GDP for Medicines: Continuing Controls and Official Certificate Updates
Before planning ‘renewal’, distinguish an official GDP inspection certificate, wholesale authorisation and any private assessment document. Identify the issuing authority, inspected premises and activities, inspection date, document status and applicable national procedure.
Before planning ‘renewal’, distinguish an official GDP inspection certificate, wholesale authorisation and any private assessment document. Identify the issuing authority, inspected premises and activities, inspection…
Clarify what an official GDP update means
Before planning ‘renewal’, distinguish an official GDP inspection certificate, wholesale authorisation and any private assessment document. Identify the issuing authority, inspected premises and activities, inspection date, document status and applicable national procedure.
EMA's procedure treats the official certificate as evidence of compliance at the inspection time; a subsequent inspection may lead to a new certificate. The general pandemic extension ended after 2024. Ask the issuing authority about the individual document rather than assuming automatic extension or a universal annual renewal.
Review continuing controls rather than reprint the file
Prepare a current view of operational changes, deviations, corrective actions, training and supplier or recipient checks. Compare actual activity with the inspected scope. A document date alone cannot establish whether changed operations remain properly controlled.
Hypothetically, the supplier spreadsheet still says ‘approved’, but the supplier's current authorisation status has changed. Compare the authentic official information with purchases and the business's approval procedure. Record what is known, unresolved and referred to the responsible person; do not invent an earlier recheck or declare medicines usable solely from the old GDP document.
Allocate follow-up and preserve the evidence
Keep the review date, records examined, changes and responsible actions visible. Explain missing evidence and verify completed corrections. Obtain the applicable authority's direction where authorisation or official status is uncertain; preparation does not substitute a regulatory decision.
Kayra can organise the agreed ongoing-compliance review and preparation for the relevant process. The business operates its controls and responsible-person decisions; the competent authority manages official inspections and certificates. No consultancy timetable guarantees a new official document or permission to continue an unconfirmed activity.
Official sources
This review supports continuing controls and an appropriate official update. It does not create automatic renewal, extend an official document or replace the competent authority.
Is an official GDP certificate simply renewed by payment?
No. Clarify the document and the authority's applicable inspection and update process.
Does the pandemic extension still apply automatically?
No. The general extension ended after 2024; ask the issuing authority about the individual case.
Does an old GDP document confirm every supplier today?
No. Supplier approval needs current evidence and the applicable rechecking procedure.
Tell us what you need and our specialists will contact you.
The exact records for GDP for Medicines: Continuing Controls and Official Certificate Updates depend on the confirmed scope. Current, consistent and traceable information reduces avoidable revisions.